Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.05
Price to sales ratio
21.61

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5009
GLMD
Galmed Pharmaceuticals Ltd. - Ordinary Shares
4.08 USD-5.34%-0.73%+655.56%+223.81%3.36 M USD
5012
XRTX
XORTX Therapeutics Inc. - Common Shares
2.34 USD-4.49%+24.47%+13.59%+203.90%3.26 M USD
5017
CRIS
Curis, Inc. - Common Stock
1.49 USD-0.67%-6.88%-70.32%-11.83%3.11 M USD
5020
ARTL
Artelo Biosciences, Inc. - Common Stock
0.66 USD0.00%-2.94%-13.16%-45.00%3.03 M USD

Frequently asked questions about Jupiter Neurosciences, Inc. Common Stock

What is the Jupiter Neurosciences, Inc. Common Stock stock price today?

The current price of Jupiter Neurosciences, Inc. Common Stock (JUNS) is 4.18. Over the past 24 hours, the stock has changed by -14.52%. Follow the JUNS chart for real-time price dynamics.

What is the stock ticker of Jupiter Neurosciences, Inc. Common Stock?

Jupiter Neurosciences, Inc. Common Stock trades under the ticker JUNS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Jupiter Neurosciences, Inc. Common Stock stock going up?

JUNS has changed by -25.49% over the last week, +4544.44% over the last month, and +631.66% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Jupiter Neurosciences, Inc. Common Stock?

Jupiter Neurosciences, Inc. Common Stock currently has a market capitalization of 3.22 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Jupiter Neurosciences, Inc. Common Stock earnings last quarter?

Last quarter, Jupiter Neurosciences, Inc. Common Stock reported earnings of -4.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Jupiter Neurosciences, Inc. Common Stock revenue for the last quarter?

Jupiter Neurosciences, Inc. Common Stock reported quarterly revenue of 24.25 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Jupiter Neurosciences, Inc. Common Stock net income for the last quarter?

Jupiter Neurosciences, Inc. Common Stock reported net income of -2.27 M for the last quarter. The previous quarter showed -2.06 M, which means net income changed by -10.30%.

How many employees does Jupiter Neurosciences, Inc. Common Stock have?

As of the latest available data, Jupiter Neurosciences, Inc. Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Jupiter Neurosciences, Inc. Common Stock stock?

You can buy Jupiter Neurosciences, Inc. Common Stock (JUNS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Jupiter Neurosciences, Inc. Common Stock stock?

Investing in Jupiter Neurosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JUNS chart and related analysis on metatrader.com as part of your research.